Julio Medina is the founder and CEO of R2M Pharma, a pharmaceutical company specializing in the development of drugs for rare diseases. Prior to starting R2M Pharma, they worked as the director of medicinal chemistry at Tularik, a biotechnology company, for over 10 years.
Some direct reports include Kevin Li - Senior Research Associate, Ulhas Bhatt - Principal Scientist.
Sign up to view 3 direct reports
Get started